⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31598680 | 1.00 | GSK3A (0.92) | — | |
| Charcoal, Activated SCHEMBL29506754 | 0.96 | GSK3A (0.85) | — | |
| SCHEMBL715867 | 0.96 | GSK3B (1.00) | — | |
| SCHEMBL33524954 | 0.96 | — | — | |
| SCHEMBL10990 | 0.96 | — | — | |
| SCHEMBL7021498 | 0.96 | — | — | |
| SCHEMBL693917 | 0.96 | GSK3B (1.00) | — | |
| SCHEMBL1599522 | 0.96 | — | — | |
| Hydrogen Sulfide SCHEMBL3713339 | 0.92 | GSK3A (0.92) | — | |
| SCHEMBL6513348 | 0.92 | GSK3A (0.92) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010118755-A1 | MALEIMIDE-N-VINYLLACTAM BASED SIDECHAIN POLYMERS FOR LCD ALIGNMENT LAYERS | KOMITOV LACHEZAR (SE) | 2010-10-21 | — | — | WO | claimed |
| US-7736635-B2 | Branched molecular scaffolds for linking polymer residues to biologically active moieties | UCB PHARMA S.A. (BE) | 2010-06-15 | — | — | US | claimed |
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2026-03-26 | — | — | US | disclosed |
| EP-4702044-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS WITH BIO-DISTRIBUTION MODIFIER | 3B Pharmaceuticals GmbH (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-20250375543-A1 | OLIGONUCLEOTIDE-BASED THERAPEUTICS AND USES THEREOF | SPEER TOD (US) | 2025-12-11 | — | — | US | disclosed |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | disclosed |
| US-20250296971-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-09-25 | — | — | US | disclosed |
| EP-4615515-A1 | LIPID NANOPARTICLE DRUG CONJUGATES | Tessera Therapeutics, Inc. (US) | 2025-09-17 | — | — | EP | disclosed |
| US-20250262312-A1 | SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS | SEAGEN INC (US) | 2025-08-21 | — | — | US | disclosed |
| EP-4583917-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2025-07-16 | — | — | EP | disclosed |
| CN-119923279-A | Prostate Specific Membrane Antigen (PSMA) ligands and uses thereof | 3B制药有限公司 | 2025-05-02 | — | — | CN | disclosed |
| US-5859261-A | PROTEIN KINASE INHIBITORS | ELI LILLY AND COMPANY (US) | 1999-01-12 | — | — | US | disclosed |
| EP-0888339-A1 | SYNTHESIS OF INDOLYLMALEIMIDES | ELI LILLY AND COMPANY (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1998011103-A1 | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS | ASTRA AKTIEBOLAG (SE) | 1998-03-19 | — | — | WO | disclosed |
| WO-1998007433-A1 | CYTOTOXIC AMINO SUGAR AND RELATED SUGAR DERIVATIVES OF INDOLOPYRROLOCARBAZOLES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-02-26 | — | — | WO | disclosed |
| US-5710228-A | Maleimide/α-olefin copolymers and their use as light stabilizers and stabilizers for organic material | BASF AKTIENGESELLSCHAFT (DE) | 1998-01-20 | — | — | US | disclosed |
| WO-1997034890-A1 | SYNTHESIS OF INDOLYLMALEIMIDES | ELI LILLY AND COMPANY (US) | 1997-09-25 | — | — | WO | disclosed |
| EP-0253586-B1 | THERMOSETTING RESIN COMPOSITION | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-09-23 | — | — | EP | disclosed |
| US-4812577-A | RADIOPHARMACEUTICAL KITS FOR LABELING ANTIBODIES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1989-03-14 | — | — | US | disclosed |
| US-4735792-A | PROTEIN BINDERS; MEDICAL DIAGNOSIS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1988-04-05 | — | — | US | disclosed |